Noninvasive biomarkers in the diagnosis of prostate cancer

Prostate cancer is responsible for 3% of all deaths in the Western world in men over 55 years old. Molecularbiomarkers represent an important diagnostic tool in prostate cancer, because at a specific stage, they reflect thephysiologic state of a cell and might be vital for the identification of earl...

Full description

Saved in:
Bibliographic Details
Published inJournal of Experimental and Molecular Biology Vol. 11; no. 2-3
Main Authors Dumache, Raluca, Puiu, Maria, Kaycsa, Adriana, David, Dana, Popovici, Marinela, Ionescu, Daniela, Miclea, Florin
Format Journal Article
LanguageEnglish
Published Iasi Universitatea "Alexandru Ioan Cuza" 01.04.2010
Online AccessGet full text

Cover

More Information
Summary:Prostate cancer is responsible for 3% of all deaths in the Western world in men over 55 years old. Molecularbiomarkers represent an important diagnostic tool in prostate cancer, because at a specific stage, they reflect thephysiologic state of a cell and might be vital for the identification of early prostate cancer and subjects at risk ofdeveloping this disease. Many biomarkers have been described in human serum, urine, seminal fluid and histologicalspecimens that exhibit varying capacities to detect prostate cancer, to monitor the disease progression, help in predictingthe disease recurrence and therapeutic treatment efficacy
ISSN:2601-6974
2601-6974